Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

136 results about "New Zealand white rabbit" patented technology

New Zealand White Rabbits are a breed of rabbit,which despite their name are commonly known to have been developed in the US. The original breeds that were used are unknown, but Suarez are believed to have played some part.

A specific antibody of major royal jelly protein MRJP1 and a preparation method thereof and Elisa quantitative detection thereof

The invention discloses a specific antibody of major royal jelly protein MRJP1 and a preparation method thereof and Elisa quantitative detection thereof. First, homology analysis is performed to amino acid sequences of proteins of all members of the Apismellifera major royal jelly protein MRJPs family (MRJP1-MRJP9) to select a specific polypeptide amino acid sequence unlike other MRJPs family members in MRJP1. The related specific polypeptide is synthesized by using a chemical method, and is used as an antigen to immunize New Zealand white rabbits; taking serum, and performing Elisa assay obtaining polyclonal antibody R2 with a relatively high titer, then purifying the antibody by using an affinity column prepared from the synthesized MRJP1 polypeptide. The titer of antibody R2 is detected via Elisa assay by using MRJP1 as the antigen, and the titer of the antibody is greater than 1:20000. The present invention provides a very reliable new rapid detection method for the qualitative and quantitative detection of MRJP1 in royal jelly, and also provides a very reliable technical means for quality control, freshness detection, and identification of genuine products of royal jelly and honey products for bee product quality supervision departments and processing and trading enterprises.
Owner:ZHEJIANG UNIV

Preparation and application of adipose-derived stem cell exosome in facial rejuvenation

The invention provides a preparation and application of an adipose-derived stem cell exosome in facial rejuvenation. The preparation method comprises the following steps: separation of adipose-derivedstem cell, extraction of the exosome and coating of adipose-derived stem cell exosome-nano collagen. By carrying out facial microscopic carving and face-lifting by virtue of the adipose-derived stemcell exosome-nano collagen, the superiorities of the adipose-derived stem cell exosome-nano collagen, compared with adipose-derived stem cell autoplastic transplantation, exosome injection or pure nano collagen, in skin reconstructive repairing and micro-face lifting are observed. Particularly, adipose-derived stem cells are separated, the exosomes of the adipose-derived stem cells are extracted,the nano collagen is fused with the separated exosome to form an adipose-derived stem cell exosome-nano collagen combined preparation, the combined preparation is injected into the skin an injured part of a New Zealand white rabbit, the promotion effect of the adipose-derived stem cell exosome-nano collagen, compared with a pure adipose-derived stem cell transplantation group, an exosome group andpure nano collagen, in the regeneration of injured skin is observed, and meanwhile, a user can observe whether the adipose-derived stem cell exosome is harmful to a human body.
Owner:王丽丽

Amantadine artificial hapten and artificial antigen as well as preparation method and application of amantadine artificial hapten and artificial antigen

The invention discloses an amantadine artificial hapten and an artificial antigen as well as a preparation method and application of the amantadine artificial hapten and the artificial antigen. The molecular structural formula of the amantadine artificial hapten is as shown in the formula (I), and the molecular structural formula of the amantadine artificial antigen is as shown in the formula (II). The application is to utilize the amantadine artificial antigen to prepare an amantadine antibody. The amantadine artificial hapten disclosed by the invention retains the feature structure of amantadine to the largest extent, comprises active groups capable of being linked and coupled with carrier protein as an antigen determinant; the prepared and obtained amantadine artificial antigen can be immunized to obtain the amantadine antibody with high affinity, high sensitivity and high specificity; the titer of immune serum obtained by immunizing a New Zealand white rabbit is up to 1:70000; the amantadine artificial hapten and the artificial antigen can be used for quick and accurate immunodetection and immunoassay to amantadine.
Owner:ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES +1

Rabbit portal vein thrombosis model

The invention relates to model preparation, particularly to a rabbit portal vein thrombosis model which establishes a rabbit portal vein thrombosis model by a portal vein ligation catheterization method. The experimental animal adopts a New Zealand white rabbit; the experimental process comprises the steps of preoperative preparation: a preoperative experimental rabbit fasts all night and freely drinks water; anaesthetization; operation method: make the preoperative preparations including shaving feathers at the operating area after anaesthetization, disinfection and the like, enter the belly layer by layer, separate a portal vein, insert a 2Fr internal jugular vein tube by a catheterization method, ligate the portal vein using the tube as the inner support, suture and fix, lead to outside of body, and then conducting firm fixing. The model of the invention causes partial blood stasis, annular oppressed damage of blood vessel endothelium by ligating the portal vein, simultaneously carries out tube stimulation, starts intrinsic and extrinsic coagulation processes, increases the incidence of thromboembolism, and provides passages for the later partially collecting blood specimen, dynamic venogram, partial injection and the like; the first PVT occurrence time is about 30 min after the model is found via the portal vein radiography, and the model formation rate is higher than 75%.
Owner:HUZHOU CENT HOSPITAL

Polyclonal antibody of dimethachlon and preparation and application thereof

InactiveCN101691404AEasy to prepareSuitable for rapid screening testsOvalbuminSerum albuminGlutaric acidNew Zealand white rabbit
The invention relates to a polyclonal antibody of dimethachlon and preparation and application thereof. The polyclonal antibody is prepared by the following steps: coupling hapten and bovine serum albumin BSA to prepare immune antigen; and immunizing New Zealand white rabbits. The polyclonal antibody is characterized in that: the hapten is dimethachlon-2-glutaric acid semi-ester; the dimethachlon-2-glutaric acid semi-ester is coupled with bovine serum albumin by an active ester method to synthesize the immune antigen; and the immune antigen is used for the New Zealand white rabbits so as to obtain the polyclonal antibody. The polyclonal antibody detects the residue of dimethachlon pesticide in a specimen by adopting an indirect competitive ELISA method; and envelope antigen used in the detection is a conjugate of the hapten and ovalbumin by the active ester method. The invention has the advantages that: the preparation method for the polyclonal antibody of the dimethachlon is simple; the polyclonal antibody can be used for quickly detecting the residue of the dimethachlon pesticide in the specimen; and compared with the prior equipmental analysis, the detection method has the advantages of simpleness, quickness, low detection cost, suitability for quickly screening a great number of samples, and the like.
Owner:JIANGSU ACADEMY OF AGRICULTURAL SCIENCES

Preparing method and detecting method for MRJR1 antibody pairs in honey and kit

The invention discloses a preparing method and a detecting method for MRJR1 antibody pairs in honey and a kit. The amino acid sequence of the specific polypeptide M4 of MRJR1 is IKEALPHVPIFD, the IKEALPHVPIFD is shown in SEQ ID NO:1; the amino acid sequence of the specific polypeptide M5 of the MRJR1 is SGEYDYKNNYPSDID, and the SGEYDYKNNYPSDID is shown in SEQ ID NO:2; New Zealand white rabbits are immunized. An ELLSA double-antibody sandwich method includes the following steps that a caught antibody SP-1 is coated, sealed and washed, an antigen is added, an enzyme-labeled detecting antibody HRP-SP-2 of an is added, washing is carried out, a color rendering substrate is added, a color rendering stopping solution is added, and the light absorption value of 450 nm-630 nm of a sample is measured through an enzyme-labeling instrument. The antigen is to-be-detected honey or pure honey of a known honey source, and the quality of the to-be-detected honey is judged by comparing the light absorption value of the MRJR1 of the to-be-detected honey and the light absorption value of the MRJR1 of the pure honey of the known honey source. According to the preparing method, the detecting method and the kit, a new reliable rapid detecting method is provided for the quality of the honey and detection of adulteration amount, and the detecting method can be used for honey-product-quality control of honey-product-quality supervision departments and honey-product-quality control of trade processing enterprises.
Owner:ZHEJIANG UNIV

Preparation method of stress phosphorylation antibody aiming at human Tudor-SN protein T73 site

InactiveCN104277110AEasy to explore correlationSerum immunoglobulinsImmunoglobulins against enzymesDiseaseHumanin
The invention discloses a stress phosphorylation antibody aiming at a human Tudor-SN protein T73 site and a preparation method thereof. The preparation method adopts a multifunctional human Tudor-SN protein as a research object and comprises the following steps of determining if threonine at a 73 site of a human Tudor-SN protein under external environment oxidation stress is subjected to phosphorylation modification by near-infrared double-color laser imaging and mass spectrometry, synthesizing a T73 phosphorylation site-containing semiantigen polypeptide according to the secondary structure prediction result, coupling the T73 phosphorylation site-containing semiantigen polypeptide and a carrier protein (KLH) into a complete antigen, carrying out immunization on SPF-level New Zealand white rabbit by the complete antigen combined with an adjuvant four times and collecting, purifying and identifying a T73 specific stress phosphorylation polyclonal antibody. In practical application, Tudor-SN protein epigenetic phosphorylation modification in different stress environments can be detected, the effect mechanism of the Tudor-SN protein epigenetic phosphorylation modification in cell stress tumor propagation and migration can be discussed and a latent action target point for clinical tumor disease diagnosis and treatment is provided.
Owner:TIANJIN MEDICAL UNIV

Preparation method of stress phosphorylation antibody aiming at human Tudor-SN protein T103 site

InactiveCN104277109AEasy to explore correlationSerum immunoglobulinsImmunoglobulins against enzymesDiseaseHumanin
The invention discloses a stress phosphorylation antibody aiming at a human Tudor-SN protein T103 site and a preparation method thereof. The preparation method adopts a multifunctional human Tudor-SN protein as a research object and comprises the following steps of determining if threonine at a 103 site of a human Tudor-SN protein under external environment oxidation stress is subjected to phosphorylation modification by near-infrared double-color laser imaging and mass spectrometry, synthesizing a T103 phosphorylation site-containing semiantigen polypeptide according to the secondary structure prediction result, coupling the T103 phosphorylation site-containing semiantigen polypeptide and a carrier protein (KLH) into a complete antigen, carrying out immunization on SPF-level New Zealand white rabbit by the complete antigen combined with an adjuvant four times and collecting, purifying and identifying a T103 specific stress phosphorylation polyclonal antibody. In practical application, Tudor-SN protein epigenetic phosphorylation modification in different stress environments can be detected, the effect mechanism of the Tudor-SN protein epigenetic phosphorylation modification in cell stress tumor propagation and migration can be discussed and a latent action target point for clinical tumor disease diagnosis and treatment is provided.
Owner:TIANJIN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products